Nanomaterial-based drug Delivery systems for ischemic stroke
C Jiang, Y Zhou, R Chen, M Yang, H Zhou, Z Tang… - Pharmaceutics, 2023 - mdpi.com
Ischemic stroke is a leading cause of death and disability in the world. At present,
reperfusion therapy and neuroprotective therapy, as guidelines for identifying effective and …
reperfusion therapy and neuroprotective therapy, as guidelines for identifying effective and …
Emerging Nanomaterials as Versatile Nanozymes: A New Dimension in Biomedical Research
The enzyme-mimicking nature of versatile nanomaterials proposes a new class of materials
categorized as nano-enzymes, ornanozymes. They are artificial enzymes fabricated by …
categorized as nano-enzymes, ornanozymes. They are artificial enzymes fabricated by …
Glutathione-IR 797 coupled Casein Nano-Trojan for augmenting the therapeutic efficacy of camptothecin in highly invasive triple negative breast cancer
The rapid metastasis & heterogenic constitution of triple negative breast cancer (TNBC)
limits drug entry to the tumor, reducing treatment effectiveness. To address this, we have …
limits drug entry to the tumor, reducing treatment effectiveness. To address this, we have …
Incorporation of Resveratrol in Polymeric Nanogel for Improvement of Its Protective Effects on Cellular and Microsomal Oxidative Stress Models
L Radeva, D Stefanova, Y Yordanov, K Kamenova… - Gels, 2023 - mdpi.com
Nanogels are attractive drug delivery systems that provide high loading capacity for drug
molecules, improve their stability, and increase cellular uptake. Natural antioxidants …
molecules, improve their stability, and increase cellular uptake. Natural antioxidants …
Revolutionizing Stroke Care: Nanotechnology-Based Brain Delivery as a Novel Paradigm for Treatment and Diagnosis
PG Balaji, LS Bhimrao, AK Yadav - Molecular Neurobiology, 2024 - Springer
Stroke, a severe medical condition arising from abnormalities in the coagulation-fibrinolysis
cycle and metabolic processes, results in brain cell impairment and injury due to blood flow …
cycle and metabolic processes, results in brain cell impairment and injury due to blood flow …
[PDF][PDF] 纳米药物在缺血性脑卒中靶向治疗中的研究进展
张敏娜， 唐仁明， 袁丽丽， 钟鸣… - 中国药理学与毒理学 …, 2023 - cjpt.magtechjournal.com
在缺血性脑卒中(IS) 发生过程中, 血管系统血栓可导致脑组织缺血缺氧, 产生炎症细胞因子引发
脑组织损伤, 缺血再灌注过程活性氧进一步引起应激性损伤. 常规给药受制于血脑屏障的选择性 …
脑组织损伤, 缺血再灌注过程活性氧进一步引起应激性损伤. 常规给药受制于血脑屏障的选择性 …
[HTML][HTML] The effect of Edaravone on clinical symptoms and oxidative stress factors in patients with acute ischemic stroke: A clinical trial
M Khazaei, F Saadati Pour, M Ghiasian… - Feyz Medical …, 2024 - feyz.kaums.ac.ir
Methods: In this clinical trial, fifty-two patients diagnosed with acute ischemic stroke were
randomly assigned to receive either Edaravone (120 mg daily up to 3 doses intravenously) …
randomly assigned to receive either Edaravone (120 mg daily up to 3 doses intravenously) …